Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin G Berger

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|December 21, 2004
The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortalityFranklin G Berger
Cancer Chemotherapy and Pharmacology|March 31, 2007
Cell death in response to antimetabolites directed at thymidylate synthaseKaren W Barbour, Franklin G Berger
Cancer Biology & Therapy|October 13, 2006
Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years?Franklin G Berger, Sondra H Berger
Advances in Cancer Research|June 21, 2021
PrefaceFranklin G Berger, C Richard Boland
The Biochemical Journal|September 7, 2010
Functional dissection of the N-terminal degron of human thymidylate synthaseSandra P Melo, Asami Yoshida, Franklin G Berger
Biochimica Et Biophysica Acta|January 17, 2004
Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthaseSondra H Berger, Franklin G Berger, Lukasz Lebioda
The Journal of Biological Chemistry|September 1, 2011
Cooperation between an intrinsically disordered region and a helical segment is required for ubiquitin-independent degradation by the proteasomeSandra P Melo, Karen W Barbour, Franklin G Berger
The EMBO Journal|April 28, 2011
USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1Xinna Zhang, Franklin G Berger, Jianhua Yang, et al.
Cytokine & Growth Factor Reviews|December 18, 2002
Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating propertiesTino Hochepied, Franklin G Berger, Heinz Baumann, et al.
Cancer Biology & Therapy|November 13, 2004
Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ miceJohn T Murphy, Jody M Tucker, Celestia Davis, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|December 21, 2004
The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortalityFranklin G Berger
Cancer Chemotherapy and Pharmacology|March 31, 2007
Cell death in response to antimetabolites directed at thymidylate synthaseKaren W Barbour, Franklin G Berger
Cancer Biology & Therapy|October 13, 2006
Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years?Franklin G Berger, Sondra H Berger
Advances in Cancer Research|June 21, 2021
PrefaceFranklin G Berger, C Richard Boland
The Biochemical Journal|September 7, 2010
Functional dissection of the N-terminal degron of human thymidylate synthaseSandra P Melo, Asami Yoshida, Franklin G Berger
Biochimica Et Biophysica Acta|January 17, 2004
Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthaseSondra H Berger, Franklin G Berger, Lukasz Lebioda
The Journal of Biological Chemistry|September 1, 2011
Cooperation between an intrinsically disordered region and a helical segment is required for ubiquitin-independent degradation by the proteasomeSandra P Melo, Karen W Barbour, Franklin G Berger
The EMBO Journal|April 28, 2011
USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1Xinna Zhang, Franklin G Berger, Jianhua Yang, et al.
Cytokine & Growth Factor Reviews|December 18, 2002
Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating propertiesTino Hochepied, Franklin G Berger, Heinz Baumann, et al.
Cancer Biology & Therapy|November 13, 2004
Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ miceJohn T Murphy, Jody M Tucker, Celestia Davis, et al.
Pageof 7